All PostsConverterAPI DocsPricingAffiliate PartnersLogin

argenx SE Price Analysis: Hammer Pattern at $697

Trader analyzing argenx SE hammer candle pattern at $697 price level
Trader analyzing argenx SE hammer candle pattern at $697 price level

A hammer candle at $697. That's what argenx SE closed with today, down 0.825% from the $703 open. Classic bullish reversal pattern, right? Except every moving average is flashing strong sell, the signal reads neutral with a -3.1 score, and the trend is labeled weak. This is what messy markets look like.

The Hammer That Nobody Trusts

Hammer patterns are supposed to mark bottoms. Long lower wick, small body, shows buyers stepped in after sellers pushed it down. ARGX printed one today at $697. Clean formation. Problem is context.

The stock opened at $703, dropped during the session, then recovered enough to close near the open. That lower wick hit buyers who thought they were getting a deal. But where are those buyers now? Price action says bullish, but the overall signal says neutral. Not exactly a ringing endorsement.

I've traded hammers before. They work when the stock is oversold, when volume confirms the bounce, when support holds. Here? The one-month low is $663.2, meaning we've got room to fall if this doesn't hold. The all-time high was $810 — we're 14% off that. Not crisis territory but not strong either.

Moving Averages All Point Down

Every single moving average is in sell mode. EMA 10 at $704.589, EMA 25 at $706.84, SMA 100 at $720.484. All above current price. All strong sell signals. That's a downtrend until proven otherwise.

When price trades below short-term EMAs, the path of least resistance is lower. The 10-day EMA is right overhead at $704 — today's open. That's now resistance. The 25-day is just above that. For ARGX to flip bullish, it needs to reclaim those levels and hold them. A single hammer candle doesn't do that.

The 100-day SMA at $720 is the bigger test. That's 3.3% above current price. If this stock is going to rally, it needs to get back above $720 and stay there. Until then, every bounce is a chance for sellers to exit.

Oscillators Give Mixed Messages

Stochastic K% sits at 37.8, signaling sell. That's below the 50 midpoint, meaning momentum favors the downside. Not deeply oversold though — that happens under 20. At 37.8, there's still room to drop before we hit panic-selling territory.

ADX is at 13.325, which gives a buy signal. That confused me at first because ADX measures trend strength, not direction. A reading under 20 means weak trend. So this "buy" signal is really just saying the trend is soft both ways. No strong directional conviction from buyers or sellers. Choppy action, not a breakout setup.

When Stochastic says sell and ADX says weak trend, you get what we have now — a stock drifting lower without strong momentum either way. The hammer candle might slow the decline, but it's not reversing anything yet.

Volatility and Pivot Points

ATR% is 2.7062, which marks high volatility. That means the stock moves around. Good for traders, stressful for holders. On any given day, ARGX can swing 2-3%. Today's drop was 0.825%, so relatively calm compared to what it's capable of.

Classic pivot points put resistance at R1 of $719.333 and support at S1 of $696.933. Price closed at $697.2, just above that support level. If $696 breaks, the next leg down starts. If it holds and price bounces back to $719, that's a 3% move — worth watching if you're trading it.

The pivot point itself sits at $707.467, which is above current price. That's the neutral zone. Above $707, bulls have control. Below it, bears do. Right now, bears are winning by a hair.

What the Numbers Actually Mean

This is a biotech stock trading below its moving averages with weak trend strength and a recent hammer candle. Translation: it's trying to find a bottom but hasn't confirmed one yet. The signal score of -3.1 is barely negative, which fits with the neutral rating. Not a disaster, not a buy signal.

For anyone looking at stock API data, this is a textbook example of conflicting indicators. Price action says one thing, moving averages say another, oscillators are split. You need to pick which signal matters most to your strategy. I weight moving averages heavy because they smooth out noise. When all of them point down, I don't fight it.

The one-month high was $737, about 5.7% above today's close. If this hammer leads to a reversal, that's the first target. But getting there means breaking through $704, $707, and $719 first. That's three resistance levels in a row. Not impossible, but not easy either.

Where This Goes Next

If $696 support breaks, I'd expect a test of the one-month low at $663. That's another 4.9% drop from here. If $696 holds and we get follow-through buying tomorrow, then $719 comes into play. The problem is I don't see what drives that follow-through. No catalyst, no volume spike, no clear oversold condition.

Hammer candles fail more often than traders admit. They need confirmation — a higher close the next day, ideally with volume. Without that, it's just a wick on a chart. I've bought hammers that turned into falling knives. I've also ignored them and missed reversals. This one feels like a coin flip, which is why the neutral signal makes sense.

The weak trend label is the most honest part of this setup. When a stock isn't trending, it's stuck. And stuck stocks either break out or break down. With moving averages overhead and no clear catalyst, breaking down seems more likely. But that hammer says buyers are lurking.

My Take

I wouldn't buy ARGX at $697. If I already owned it, I'd hold but set a stop at $690 to protect against a break of support. The moving averages are too negative, the trend is too weak, and one hammer candle isn't enough to override that. Maybe this marks the bottom. Maybe it's a dead-cat bounce before another leg down.

If you're looking for real-time stock data access to track setups like this, FCS API covers the technicals that matter. For more breakdowns on stocks showing mixed signals, check the blog for updated analysis.

I'd wait for price to reclaim $707 and hold it for at least two days before I'd consider this buyable. Until then, it's a stock in no-man's-land — not crashing, not rallying, just sitting there while traders argue about what comes next.

Share this article:
FCS API
Written by

FCS API Editorial

Market analyst and financial content writer at FCS API.